# Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients

> **NCT05901025** · — · NOT_YET_RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 5000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05901025
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-05
- **Primary completion:** 2028-06-30
- **Final completion:** 2033-06-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901025, "Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05901025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*